Wednesday, April 30, 2008
The American Academy of Neurology had its annual meeting recently, where the newest in research is presented with the hope of better treatments. At this year's meeting, we heard a lot about updates of clinical trials we are all becoming familiar with:
Rituximab - the monoclonal antibody directed a...
I suffer from Multiple Sclerosis and I am told that it is RRMS. Doesn't feel like relapsing or remitting as I lose function. It's a terrible thing to actually become jealous of someone's ability to walk. I am a registered nurse- and unable to work in my field because no one wants a nurse who cannot provide bedside care, much less has a progressive neurological disease! What I have right now is a living existence- not a life. If this drug works as well as the studies report, even half as well as reported, I for one am willing to risk the side effects in hope of maintaining what function I do have left.